Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP23711.RAXEVAcrI9ml3kE4roElajdloOu2GS3U1bg3R_PFJyTCM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP23711.RAXEVAcrI9ml3kE4roElajdloOu2GS3U1bg3R_PFJyTCM130_assertion type Assertion NP23711.RAXEVAcrI9ml3kE4roElajdloOu2GS3U1bg3R_PFJyTCM130_head.
- NP23711.RAXEVAcrI9ml3kE4roElajdloOu2GS3U1bg3R_PFJyTCM130_assertion description "[In late-onset bortezomib-induced peripheral neuropathy, the significant genes were SOD2 (upregulated by 118 times; p=9610(-3)) and MYO5A (193 times; p=3210(-2)), involved in development and function of the nervous system.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23711.RAXEVAcrI9ml3kE4roElajdloOu2GS3U1bg3R_PFJyTCM130_provenance.
- NP23711.RAXEVAcrI9ml3kE4roElajdloOu2GS3U1bg3R_PFJyTCM130_assertion evidence source_evidence_curated NP23711.RAXEVAcrI9ml3kE4roElajdloOu2GS3U1bg3R_PFJyTCM130_provenance.
- NP23711.RAXEVAcrI9ml3kE4roElajdloOu2GS3U1bg3R_PFJyTCM130_assertion SIO_000772 20864405 NP23711.RAXEVAcrI9ml3kE4roElajdloOu2GS3U1bg3R_PFJyTCM130_provenance.
- NP23711.RAXEVAcrI9ml3kE4roElajdloOu2GS3U1bg3R_PFJyTCM130_assertion wasDerivedFrom ctd_human-20130708 NP23711.RAXEVAcrI9ml3kE4roElajdloOu2GS3U1bg3R_PFJyTCM130_provenance.
- NP23711.RAXEVAcrI9ml3kE4roElajdloOu2GS3U1bg3R_PFJyTCM130_assertion wasGeneratedBy ECO_0000218 NP23711.RAXEVAcrI9ml3kE4roElajdloOu2GS3U1bg3R_PFJyTCM130_provenance.